2 completed, 2 unknown, 1 terminated. 5 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 5 | Completed 2, Unknown 2, Terminated 1 |
Follow Abraxane: new trials by email Literature Review of Abraxane trials Research Report on Abraxane
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Abraxane Combined With Xeloda as Neo-Adjuvant Chemotherapy in Early Breast Cancer Abraxane, Xeloda - Breast Cancer | Not applicable | Unknown | Zhejiang Cancer Hospital | 50 | 2018-12-01 | 2018-12-10 |
| The Efficacy and Safety of Abraxane Combined With Epirubicin as Neoadjuvant Chemotherapy in Breast Cancer Abraxane, Epirubicin - Breast Cancer | Not applicable | Unknown | Zhejiang Cancer Hospital | 50 | 2018-12-01 | 2018-12-07 |
| Endoscopic Abraxane Injection Into Pancreatic Cysts Albumin bound paclitaxel - Pancreatic Cysts | Not applicable | Terminated | Massachusetts General Hospital | 5 | 2012-11-01 | 2017-06-21 |
| Assessment Of Stromal Response To Nab-Paclitaxel In Combination With Gemcitabine In Pancreatic Cancer Gemcitabine plus nab-paclitaxel - Pancreatic Cancer | Not applicable | Completed | Grupo Hospital de Madrid | 15 | 2011-01-01 | 2013-03-13 |
| Dose Dense Abraxane in Adjuvant Chemotherapy for Breast Cancer Abraxane - Breast Cancer | Not applicable | Completed | Harold J. Burstein, MD, PhD | 66 | 2006-03-01 | 2013-02-18 |
Breast Neoplasms (3) · Pancreatic Cyst (1) · Pancreatic Neoplasms (1) · Precancerous Conditions (1)
Zhejiang Cancer Hospital (2) · Grupo Hospital de Madrid (1) · Harold J. Burstein, MD, PhD (1) · Massachusetts General Hospital (1)
Spain (1) · United States (1)
Ding Xiaowen, DR. (1) · Ding Xiaowen, Doc (1) · Harold Burstein, MD (1) · Manuel Hidalgo, MD, PhD (1) · William Brugge, MD (1)